Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwabe Austria is a leading Austrian pharmaceutical company specializing in phytotherapy (herbal medicines) and homeopathic products. As a subsidiary of the German Schwabe Group, the company was formed through the integration and rebranding of Austroplant-Arzneimittel and Dr. Peithner KG. Schwabe Austria manufactures and distributes well-known plant-based medicines, including Kaloba, Passedan, Crataegutt, Lasea, and Vitango, targeting indications such as respiratory tract infections, anxiety, sleep disorders, and cognitive decline. The company serves as a regional hub for Central and Eastern Europe, managing operations in Austria, the Czech Republic, Slovakia, and Hungary.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwabe Austria.